In colon, hepatocellular carcinoma (HCC), breast, renal carcinoma (RCC), and cervical cancer, decreased AIM2 expression promotes tumorigenesis and affects patient prognosis. The gene discussed is AIM2; the disease is hepatocellular carcinoma.